Editor: "Atta-ur-Rahman "

Advances in Cancer Drug Targets

Volume 3

Personal Book: US $89 Special Offer (PDF + Printed Copy): US $163
Printed Copy: US $119
Library Book: US $356
ISSN: 2451-8891
eISSN: 2213-9915 (Online)
ISBN: 978-1-68108-234-9
eISBN: 978-1-68108-233-2 (Online)
DOI: 10.2174/97816810823321160301

Introduction

Advances in Cancer Drug Targets is an e-book series that brings together recent expert reviews published on the subject with a focus on strategies for synthesizing and isolating organic compounds and elucidating the structure and nature of DNA.

The reviews presented in this series are written by experts in pharmaceutical sciences and molecular biology. These reviews have been carefully selected to present development of new approaches to anti-cancer therapy and anti-cancer drug development.

The contents of this volume include reviews on mediating or inhibiting different signaling pathways such as WNT signaling and MTOR as well as novel drug targets for tumor control such as neutrophil elastase and estrogen sulfatase. These reviews provide updates on new ways to treat a variety of cancers.

The reference work serves to give readers a brief yet comprehensive glance at current theory and practice behind employing chemical compounds for tackling tumor suppression, DNA site specific drug targeting and the inhibition of enzymes involved in growth control pathways. This e-book volume will be of special interest to molecular biologists and pharmaceutical scientists.

Contributors

Editor(s):
Atta-ur-Rahman
Kings College, University of Cambridge
Honorary Life Fellow
Cambridge
UK




Contributor(s):
Alain J.P. Alix
Institut de Chimie Moléculaire de Reims & Laboratoire de Spectroscopies et Structures Biomoléculaires
Faculté des Sciences, IFR53 Biomolécules, BP 1039, 51687
Université de Reims Champagne-Ardenne, CNRS UMR 6229
Reims Cedex
France


Alessandro Palmioli
Department of Biotechnology and Biosciences
University of Milano-Bicocca
Piazza della Scienza 2, 20126
Milano
Italy


Alicia Gonzlez
Department of Physiology and Pharmacology
School of Medicine, University of Cantabria and Instituto de Investigación Valdecilla (IDIVAL)
39011 Santander
Spain


E. Chan
Department of Obstetrics and Gynaecology
University of Melbourne
Melbourne
Australia


Carolina Martínez-Campa
Department of Physiology and Pharmacology
School of Medicine, University of Cantabria and Instituto de Investigación Valdecilla (IDIVAL)
39011 Santander
Spain


Cristina Airoldi
Department of Biotechnology and Biosciences
University of Milano-Bicocca
Piazza della Scienza 2, 20126
Milano
Italy


Enzo Martegani
Department of Biotechnology and Biosciences
University of Milano-Bicocca
Piazza della Scienza 2, 20126
Milano
Italy


Erika Bourguet
Institut de Chimie Moléculaire de Reims, Faculté de Pharmacie, IFR53 Biomolécules, 51 rue de Cognacq-Jay
Université de Reims Champagne-Ardenne, CNRS UMR 6229
51096 Reims Cedex
France


Francesco Peri
Department of Biotechnology and Biosciences
University of Milano-Bicocca
Piazza della Scienza 2, 20126
Milano
Italy


G. Kannourakis
Fiona Elsey Cancer Research Institute
Ballarat
Australia
/
Federation University
Ballarat
Australia


G.B.K.S. Prasad
School of Studies in Biochemistry
Jiwaji University
Gwalior 474011
India


Giese Thomas
Institute of Immunology, University of Heidelberg
Heidelberg
Germany


Hongyu Zhou
Department of Biochemistry and Molecular Biology
Louisiana State University, Health Sciences Center
1501 Kings Highway
Shreveport
LA, 71130-3932
USA


J.K. Findlay
Department of Obstetrics and Gynaecology
University of Melbourne
Melbourne
Australia
/
Hudson Institute of Medical Research
Melbourne
Australia


Jack R. Wands
Institute of Immunology
Rhode Island Hospital and the Warren Alpert Medical School of Brown University
Providence, RI
USA


Janos SAPI
Institut de Chimie Moléculaire de Reims & Laboratoire de Spectroscopies et Structures Biomoléculaires, Faculté des Sciences
IFR53 Biomolécules, BP 1039, 51687, Université de Reims Champagne-Ardenne, CNRS UMR 6229
Reims Cedex
France


K. Abubaker
Department of Obstetrics and Gynaecology
University of Melbourne
Melbourne
Australia


Luca De Gioia
Department of Biotechnology and Biosciences
University of Milano-Bicoccaz
Piazza della Scienza 2, 20126
Milano
Italy


Michael Kirschfink
Institute of Immunology, University of Heidelberg
Heidelberg
Germany


Miran Kim
Institute of Immunology
Rhode Island Hospital and the Warren Alpert Medical School of Brown University
Providence, RI
USA


Moroy Gautier
Molécules thérapeutiques in silico
Université Paris Diderot
INSERM UMRS-973
Bât


N. Ahmed
Fiona Elsey Cancer Research Institute
Ballarat
Australia
/
Department of Surgery, University of Melbourne
Melbourne
Australia
/
Department of Obstetrics and Gynaecology
University of Melbourne
Melbourne
Australia
/
Hudson Institute of Medical Research
Melbourne
Australia


N. Khan
Division of Plant-Microbe Interactions
National Botanical Research Institute
Rana Pratap Marg, Lucknow
India


Nicolas Geis
Institute of Immunology
University of Heidelberg
Heidelberg
Germany


P. S. Bisen
School of Studies in Biotechnology
Jiwaji University
Gwalior 474011
India


Renate Rutz
Institute of Immunology
University of Heidelberg
Heidelberg
Germany


Renata Tisi
Department of Biotechnology and Biosciences
University of Milano-Bicocca
Piazza della Scienza 2, 20126
Milano
Italy


Samuel Cos
Department of Physiology and Pharmacology, School of Medicine
University of Cantabria and Instituto de Investigación Valdecilla (IDIVAL)
39011 Santander
Spain


Sandro Olivieri
Department of Biotechnology and Biosciences
University of Milano-Bicocca
Piazza della Scienza 2, 20126
Milano
Italy


Shile Huang
Department of Biochemistry and Molecular Biology
Health Louisiana State University
Sciences Center, 1501 Kings Highway
Shreveport
LA, 71130-3932
USA
/
Feist-Weiller Cancer Center, Louisiana State University
Health Louisiana State University
Sciences Center, 1501 Kings Highway
Shreveport
LA, 71130-3932
USA


Simon Höne
Institute of Immunology
University of Heidelberg
Heidelberg
Germany


Sonia Colombo
Department of Biotechnology and Biosciences
University of Milano-Bicocca, Piazza della Scienza 2, 20126
Milano
Italy


Sonia Fantinato
Department of Biotechnology and Biosciences
University of Milano-Bicocca, Piazza della Scienza 2, 20126
Milano
Italy


Srinivas Mamidi
Institute of Immunology
University of Heidelberg
Heidelberg
Germany


Stefanie Zell
Institute of Immunology
University of Heidelberg
Heidelberg
Germany


Stefan Schultz
Institute of Immunology
University of Heidelberg
Heidelberg
Germany


Virginia álvarez-García
Department of Physiology and Pharmacology, School of Medicine
University of Cantabria and Instituto de Investigación Valdecilla (IDIVAL)
39011 Santander
Spain


Wenhan Li
Institute of Immunology
University of Heidelberg
Heidelberg
Germany


William Hornebeck
Institut de Chimie Moléculaire de Reims, Faculté de Pharmacie, IFR53 Biomolécules, 51 rue de Cognacq-Jay
Université de Reims Champagne-Ardenne, CNRS UMR 6229
51096 Reims Cedex
France


Z. Khan
Department of Biomedical Sciences and Pathology and Laboratory Medicine
Cedars-Sinai Medical Center
Los Angeles
CA, 90048
USA




RELATED BOOKS

.Advances in Cancer Nanotheranostics for Experimental and Personalized Medicine.
.Current Advances in Breast Cancer Research: A Molecular Approach.
.Avastin and Malignant Gliomas .
.Cutting Edge Therapies for Cancer in the 21 Century.